| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |